Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

about

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

Item

http://www.wikidata.org/entity/Q52606149

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

@en

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

@nl

type

Item

label

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

@en

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

@nl

prefLabel

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

@en

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

@nl

P1476

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.

@en

P2093

Imerio Capone

http://www.w3.org/2001/XMLSchema#string

Paolo Marchetti

http://www.w3.org/2001/XMLSchema#string

Walter Malorni

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity management of immunotherapy for patients with metastatic melanoma

Regulation of type I interferon responses

Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Pembrolizumab for the treatment of non-small-cell lung cancer

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma

Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.

P304

552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.00552

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Antonio Ascierto

Lucia Gabriele

P577

2018-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29619026

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5871673

http://www.w3.org/2001/XMLSchema#string